Header cover image

Japanese (NIKKEI) Healthcare Sector Analysis

UpdatedApr 15, 2025
DataAggregated Company Financials
Companies210
  • 7D1.5%
  • 3M-11.0%
  • 1Y-5.3%
  • YTD-11.7%

In the last week, the Healthcare industry is up 1.5%, with Chugai Pharmaceutical up 3.3%. In the same time, Daiichi Sankyo Company was down 6.0%. However, the industry is down 5.3% over the past year. Earnings are forecast to grow by 11% annually.

Sector Valuation and Performance

Has the Japanese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 15 Apr 2025JP¥58.1tJP¥37.5tJP¥2.4t14x24.2x1.5x
Thu, 13 Mar 2025JP¥62.8tJP¥37.5tJP¥2.4t15.4x26.3x1.7x
Sat, 08 Feb 2025JP¥64.0tJP¥37.1tJP¥2.1t15.4x29.9x1.7x
Mon, 06 Jan 2025JP¥67.2tJP¥36.7tJP¥2.2t16.6x30x1.8x
Wed, 04 Dec 2024JP¥69.1tJP¥36.7tJP¥2.2t16x30.8x1.9x
Fri, 01 Nov 2024JP¥71.7tJP¥36.2tJP¥2.1t17.4x34.9x2x
Sun, 29 Sep 2024JP¥70.8tJP¥36.0tJP¥2.0t17.6x35.7x2x
Tue, 27 Aug 2024JP¥72.8tJP¥36.0tJP¥2.0t17.5x36.7x2x
Thu, 25 Jul 2024JP¥69.7tJP¥35.1tJP¥1.8t18.2x37.8x2x
Sat, 22 Jun 2024JP¥64.7tJP¥35.3tJP¥1.9t17.8x34.6x1.8x
Mon, 20 May 2024JP¥65.6tJP¥35.3tJP¥1.9t17.4x35.1x1.9x
Wed, 17 Apr 2024JP¥62.5tJP¥34.7tJP¥1.9t17.5x32.1x1.8x
Fri, 15 Mar 2024JP¥67.3tJP¥35.1tJP¥2.0t18.4x34.3x1.9x
Sun, 11 Feb 2024JP¥65.5tJP¥35.1tJP¥2.1t18.5x31.9x1.9x
Tue, 09 Jan 2024JP¥63.8tJP¥35.0tJP¥2.2t18.7x29.6x1.8x
Thu, 07 Dec 2023JP¥64.5tJP¥35.0tJP¥2.2t17.7x30x1.8x
Sat, 04 Nov 2023JP¥61.4tJP¥34.7tJP¥2.2t17.2x28.1x1.8x
Mon, 02 Oct 2023JP¥63.2tJP¥34.5tJP¥2.3t17.7x27.8x1.8x
Wed, 30 Aug 2023JP¥64.2tJP¥34.5tJP¥2.3t18.1x28.4x1.9x
Fri, 28 Jul 2023JP¥63.9tJP¥34.0tJP¥2.3t18.4x27.5x1.9x
Sun, 25 Jun 2023JP¥66.3tJP¥33.9tJP¥2.3t18.7x28.6x2x
Tue, 23 May 2023JP¥64.5tJP¥33.9tJP¥2.3t18.8x27.9x1.9x
Thu, 20 Apr 2023JP¥61.9tJP¥33.5tJP¥2.3t17x26.9x1.8x
Sat, 18 Mar 2023JP¥60.0tJP¥33.5tJP¥2.3t16.8x26.1x1.8x
Mon, 13 Feb 2023JP¥60.3tJP¥33.4tJP¥2.3t16.4x26.4x1.8x
Wed, 11 Jan 2023JP¥58.1tJP¥32.4tJP¥2.2t15.6x26.7x1.8x
Fri, 09 Dec 2022JP¥62.9tJP¥32.4tJP¥2.2t16x28.9x1.9x
Sun, 06 Nov 2022JP¥62.5tJP¥32.1tJP¥2.2t15.3x28.3x1.9x
Tue, 04 Oct 2022JP¥61.3tJP¥31.7tJP¥2.3t15.5x27.1x1.9x
Thu, 01 Sep 2022JP¥62.7tJP¥31.7tJP¥2.3t16.1x27.7x2x
Sat, 30 Jul 2022JP¥62.0tJP¥31.3tJP¥2.3t16.5x27.3x2x
Mon, 27 Jun 2022JP¥58.1tJP¥31.3tJP¥2.3t16.1x25.2x1.9x
Wed, 25 May 2022JP¥58.2tJP¥31.3tJP¥2.3t15.3x25.2x1.9x
Fri, 22 Apr 2022JP¥59.6tJP¥30.7tJP¥2.4t17.5x24.9x1.9x
Price to Earnings Ratio

24.9x


Total Market Cap: JP¥59.6tTotal Earnings: JP¥2.4tTotal Revenue: JP¥30.7tTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Healthcare Sector Price to Earnings3Y Average 29.5x202320242025
Current Industry PE
  • Investors are pessimistic on the Japanese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 24.2x which is lower than its 3-year average PE of 29.5x.
  • The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.5x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 6.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare sector?

JP Market8.73%
Healthcare1.49%
Biotech21.08%
Healthtech11.96%
Life Sciences10.57%
Healthcare Services8.18%
Medical Equipment3.40%
Pharma-0.68%
Industry PE
  • Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 60.7x.
    • Analysts are expecting annual earnings growth of 16.4%, which is higher than its past year's earnings decline of 8.1% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 18% over the next 5 years.
  • This is better than its past earnings decline of 2.0% per year.
  • In contrast, the Healthcare Services industry is expected to see its earnings grow by 7.5% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
7741 HOYAJP¥15.71k4.3%
+JP¥221.1b
-10.2%PE25.9x
4519 Chugai PharmaceuticalJP¥6.62k1.2%
+JP¥128.4b
29.0%PE28.1x
2413 M3JP¥1.69k5.2%
+JP¥57.4b
-12.3%PE27.9x
4151 Kyowa KirinJP¥2.17k4.3%
+JP¥46.6b
-18.5%PE18.9x
4530 Hisamitsu PharmaceuticalJP¥4.41k12.6%
+JP¥36.2b
16.1%PE14.8x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

8129

JP¥4,868.00

Toho Holdings

7D

13.0%

1Y

32.4%

4530

JP¥4,412.00

Hisamitsu Pharmaceutical

7D

12.6%

1Y

16.1%

4519

JP¥6,620.00

Chugai Pharmaceutical

7D

1.2%

1Y

29.0%

7730

JP¥1,062.50

Mani

7D

-12.9%

1Y

-41.5%

4568

JP¥3,211.00

Daiichi Sankyo Company

7D

-4.3%

1Y

-29.5%

2413

JP¥1,694.50

M3

7D

5.2%

1Y

-12.3%

4502

JP¥4,174.00

Takeda Pharmaceutical

7D

-0.9%

1Y

1.3%

4592

JP¥2,138.00

SanBio

7D

29.3%

1Y

420.2%

4543

JP¥2,704.00

Terumo

7D

-0.9%

1Y

2.4%

4536

JP¥1,336.50

Santen Pharmaceutical

7D

-4.7%

1Y

-7.2%